These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 7511575

  • 21. Enhancement of reversing effect of cyclosporin A on vincristine resistance by anti-P-glycoprotein monoclonal antibody MRK-16.
    Naito M, Tsuge H, Kuroko C, Tomida A, Tsuruo T.
    Jpn J Cancer Res; 1993 May; 84(5):489-92. PubMed ID: 8100562
    [Abstract] [Full Text] [Related]

  • 22. Reversal of multidrug resistance by an immunosuppressive agent FK-506.
    Naito M, Oh-hara T, Yamazaki A, Danki T, Tsuruo T.
    Cancer Chemother Pharmacol; 1992 May; 29(3):195-200. PubMed ID: 1370765
    [Abstract] [Full Text] [Related]

  • 23. Monocytes and the 38kDa-antigen of mycobacterium tuberculosis modulate natural killer cell activity and their cytolysis directed against ovarian cancer cell lines.
    Gottschalk N, Lang S, Kimmig R, Singh M, Brandau S.
    BMC Cancer; 2012 Oct 04; 12():451. PubMed ID: 23036052
    [Abstract] [Full Text] [Related]

  • 24. Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo.
    Watanabe T, Tsuge H, Oh-Hara T, Naito M, Tsuruo T.
    Acta Oncol; 1995 Oct 04; 34(2):235-41. PubMed ID: 7718262
    [Abstract] [Full Text] [Related]

  • 25. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
    Jiang XR, Kelsey SM, Wu YL, Newland AC.
    Br J Haematol; 1995 Jun 04; 90(2):375-83. PubMed ID: 7794760
    [Abstract] [Full Text] [Related]

  • 26. Susceptibility of multidrug-resistant human T-lymphoblastoid CEM cell line to cell-mediated cytolysis.
    Ramoni C, Dupuis ML, Cenciarelli C, Ciccolini F, Cianfriglia M.
    Ann Ist Super Sanita; 1990 Jun 04; 26(3-4):433-9. PubMed ID: 1982604
    [Abstract] [Full Text] [Related]

  • 27. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L, Adams M, Carter T, Chen R, Muller G, Stirling D, Schafer P, Bartlett JB.
    Clin Cancer Res; 2008 Jul 15; 14(14):4650-7. PubMed ID: 18628480
    [Abstract] [Full Text] [Related]

  • 28. Surface receptors and immune activity of purified human circulating mononuclear cells. III. The mechanisms of lysis, by lymphocytes and monocytes, of target cells in the lymphocyte-dependent and monocyte-dependent ADCC, NK, NOCC, and MICC cytotoxic reactions.
    Richter M, Kazaniwsky N.
    Cell Immunol; 1987 Sep 15; 108(2):297-312. PubMed ID: 3621351
    [Abstract] [Full Text] [Related]

  • 29. Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil.
    Shrivastava P, Hanibuchi M, Yano S, Parajuli P, Tsuruo T, Sone S.
    Cancer Chemother Pharmacol; 1998 Sep 15; 42(6):483-90. PubMed ID: 9788575
    [Abstract] [Full Text] [Related]

  • 30. Chemosensitisation by verapamil and cyclosporin A in mouse tumour cells expressing different levels of P-glycoprotein and CP22 (sorcin).
    Twentyman PR, Reeve JG, Koch G, Wright KA.
    Br J Cancer; 1990 Jul 15; 62(1):89-95. PubMed ID: 1975203
    [Abstract] [Full Text] [Related]

  • 31. Paclitaxel enhances antibody-dependent cell-mediated cytotoxicity of trastuzumab by rapid recruitment of natural killer cells in HER2-positive breast cancer.
    Miura D, Yoneyama K, Furuhata Y, Shimizu K.
    J Nippon Med Sch; 2014 Jul 15; 81(4):211-20. PubMed ID: 25186575
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
    Van Acker KL, Van Hove LM, Boogaerts MA.
    Cytometry; 1993 Oct 15; 14(7):736-46. PubMed ID: 7902231
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Macrophage colony-stimulating factor enhancement of antibody-dependent cellular cytotoxicity against human colon carcinoma cells.
    Qi CF, Nieroda C, De Filippi R, Greiner JW, Correale P, Schlom J, Tsang KY.
    Immunol Lett; 1995 Oct 15; 47(1-2):15-24. PubMed ID: 8537095
    [Abstract] [Full Text] [Related]

  • 35. The strong in vivo anti-tumor effect of the UIC2 monoclonal antibody is the combined result of Pgp inhibition and antibody dependent cell-mediated cytotoxicity.
    Szalóki G, Krasznai ZT, Tóth Á, Vízkeleti L, Szöllősi AG, Trencsényi G, Lajtos I, Juhász I, Krasznai Z, Márián T, Balázs M, Szabó G, Goda K.
    PLoS One; 2014 Oct 15; 9(9):e107875. PubMed ID: 25238617
    [Abstract] [Full Text] [Related]

  • 36. [Mechanism of multidrug resistant tumors and chemotherapeutic approaches against the resistant tumors].
    Tsuruo T.
    Yakugaku Zasshi; 1997 Aug 15; 117(8):455-67. PubMed ID: 9306724
    [Abstract] [Full Text] [Related]

  • 37. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
    Ortaldo JR, Woodhouse C, Morgan AC, Herberman RB, Cheresh DA, Reisfeld R.
    J Immunol; 1987 May 15; 138(10):3566-72. PubMed ID: 2437198
    [Abstract] [Full Text] [Related]

  • 38. Within peripheral blood mononuclear cells, antibody-dependent cellular cytotoxicity of rituximab-opsonized Daudi cells is promoted by NK cells and inhibited by monocytes due to shaving.
    Beum PV, Lindorfer MA, Taylor RP.
    J Immunol; 2008 Aug 15; 181(4):2916-24. PubMed ID: 18684983
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Killing of human tumor cell lines by human monocytes and murine monoclonal antibodies.
    Lubeck MD, Kimoto Y, Steplewski Z, Koprowski H.
    Cell Immunol; 1988 Jan 15; 111(1):107-17. PubMed ID: 3338092
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.